Phlo, a Glasgow, UK-based digital pharmacy company, raised £10M in Series A funding, a combination of equity investment and the conversion of existing loan notes.
The round was led by Thairm Bio, alongside support from Scottish Enterprise and a number of other high-profile angel investors.
The company intends to use the funds to expand the reach of Phlo Digital Pharmacy, and to scale Phlo Connect, a digital infrastructure platform for healthcare providers.
Led by CEO Nadeem Sarwar, Phlo provides a UK digital pharmacy currently offering a same-day NHS and private prescription delivery service to patients in Birmingham and London, and launching in Manchester in 2023. Over 110,000 orders have been delivered since the platform’s launch in 2020, with user numbers more than doubling year-on-year. The company’s second product, Phlo Connect, provides digital pharmacy infrastructure that enables healthtech companies and private healthcare providers to offer a seamless digital pharmacy service.
Phlo existing partners include Babylon, Leva Clinic, SkinDoc, Syrona Health, and The Dermatology Partnership.
FinSMEs
03/02/2023